Concepedia

Khaliquzzaman Samad

KS

Statistics

Publications

2

Citations

85

H-Index

2

Active since

2009

Affiliations

Harrington Cancer Center(Current)

Bristol Hospital

Texas Tech University Health Sciences Center

Texas Tech University

Amarillo VA Health Care System

Khaliquzzaman Samad is an author at Harrington Cancer Center specializing in immunotherapy, antitumor t cell responses, and tumor-infiltrating lymphocytes.

Publications per year

2009–2011

2

Publications

2

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Khaliquzzaman Samad et al. · Cancer Immunology Immunotherapy · 2011 · 49 citations

, , +16

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Imelda S. Quinlin et al. · Clinical Immunology · 2009 · 36 citations

, , +16

1–2 of 2